Skip to main content
SpringerLink
Log in

Impact of serum uric acid, albumin and their interaction on Parkinson’s disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The study aimed to investigate the correlation between Parkinson’s disease (PD) and serum levels of uric acid (UA), albumin and their interaction. A cross-sectional study was conducted to evaluate the relationship of serum UA, albumin with PD. A total of 96 PD patients and 108 healthy controls were recruited at Huai’an First People’s Hospital, Nanjing Medical University. Baseline data included age, gender, body mass index (BMI), disease duration, Hoehn and Yahr scale (H&Y) stage, serum UA and albumin levels. The levels of serum UA and albumin were significantly lower in PD patients than those in controls (P = 0.001; P = 0.000). Serum albumin levels were strikingly different in H&Y group (P = 0.004). Multivariable logistic regression showed that the levels of serum UA (P = 0.001, adjusted OR 0.993, 95% CI 0.988–0.997) and albumin (P = 0.000, adjusted OR 0.513, 95% CI 0.425–0.620) were independent risk factors in PD. The receiver operating characteristic (ROC) curve analyses showed that the area under curve (AUC) for serum UA and albumin was 0.669 (95% CI 0.594–0.744) and 0.883 (95% CI 0.835–0.931), respectively. The combination of serum albumin and UA improved the AUC to 0.898 (95% CI 0.854–0.942). Serum UA and albumin levels significantly decreased in PD patients and were independent risk factors for PD. More studies are needed to confirm our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53(Suppl 3):S26–S36. doi:10.1002/ana.10483 (discussion S36–28)

    Article  CAS  PubMed  Google Scholar 

  2. Schlesinger I, Schlesinger N (2008) Uric acid in Parkinson’s disease. Mov Disord: Off J Mov Disord Soc 23(12):1653–1657. doi:10.1002/mds.22139

    Article  Google Scholar 

  3. Zhu TG, Wang XX, Luo WF et al (2012) Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action. Neurosci Lett 506(2):175–179. doi:10.1016/j.neulet.2011.10.075

    Article  CAS  PubMed  Google Scholar 

  4. Jesus S, Perez I, Caceres-Redondo MT et al (2013) Low serum uric acid concentration in Parkinson’s disease in southern Spain. Eur J Neurol 20(1):208–210. doi:10.1111/j.1468-1331.2012.03745.x

    Article  CAS  PubMed  Google Scholar 

  5. Annanmaki T, Muuronen A, Murros K (2007) Low plasma uric acid level in Parkinson’s disease. Mov Disord: Off J Mov Disord Soc 22(8):1133–1137. doi:10.1002/mds.21502

    Article  Google Scholar 

  6. Jain S, Ton TG, Boudreau RM et al (2011) The risk of Parkinson disease associated with urate in a community-based cohort of older adults. Neuroepidemiology 36(4):223–229. doi:10.1159/000327748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chen H, Mosley TH, Alonso A et al (2009) Plasma urate and Parkinson’s disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 169(9):1064–1069. doi:10.1093/aje/kwp033

    Article  PubMed  PubMed Central  Google Scholar 

  8. Weisskopf MG, O’Reilly E, Chen H et al (2007) Plasma urate and risk of Parkinson’s disease. Am J Epidemiol 166(5):561–567. doi:10.1093/aje/kwm127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ferro JM, Davalos A (2006) Other neuroprotective therapies on trial in acute stroke. Cerebrovasc Dis 21(Suppl 2):127–130. doi:10.1159/000091712

    Article  CAS  PubMed  Google Scholar 

  10. Peng F, Yang Y, Liu J et al (2012) Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica. Eur J Neurol 19(2):277–283. doi:10.1111/j.1468-1331.2011.03488.x

    Article  CAS  PubMed  Google Scholar 

  11. Xu WH, Dong C, Rundek T et al (2014) Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study. Stroke; J Cereb Circ 45(4):973–978. doi:10.1161/STROKEAHA.113.003835

    Article  CAS  Google Scholar 

  12. Hostmark AT, Tomten SE (2006) Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study. Eur J Cardiovasc Prev Rehabil: Off J Eur Soc Cardiol Work Groups Epidemiol Prev Cardiac Rehabil Exerc Physiol 13(1):87–90

    Article  Google Scholar 

  13. Gillum RF, Ingram DD, Makuc DM (1994) Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 140(10):876–888

    CAS  PubMed  Google Scholar 

  14. Kim TH, Lee JH (2014) Serum uric acid and nigral iron deposition in Parkinson’s disease: a pilot study. PLoS One 9(11):e112512. doi:10.1371/journal.pone.0112512

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zhang HN, Guo JF, He D et al (2012) Lower serum UA levels in Parkinson’s disease patients in the Chinese population. Neurosci Lett 514(2):152–155. doi:10.1016/j.neulet.2012.02.077

    Article  CAS  PubMed  Google Scholar 

  16. Regoli F, Winston GW (1999) Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol 156(2):96–105. doi:10.1006/taap.1999.8637

    Article  CAS  PubMed  Google Scholar 

  17. Skinner KA, White CR, Patel R et al (1998) Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor. J Biol Chem 273(38):24491–24497

    Article  CAS  PubMed  Google Scholar 

  18. Grimm G, Haslacher H, Kampitsch T et al (2009) Sex differences in the association between albumin and all-cause and vascular mortality. Eur J Clin Investig 39(10):860–865. doi:10.1111/j.1365-2362.2009.02189.x

    Article  CAS  Google Scholar 

  19. Idicula TT, Waje-Andreassen U, Brogger J et al (2009) Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study. Cerebrovasc Dis 28(1):13–17. doi:10.1159/000215938

    Article  CAS  PubMed  Google Scholar 

  20. Taverna M, Marie AL, Mira JP et al (2013) Specific antioxidant properties of human serum albumin. Ann Intensive Care 3(1):4. doi:10.1186/2110-5820-3-4

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zhang WJ, Frei B (2002) Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 55(4):820–829

    Article  CAS  PubMed  Google Scholar 

  22. Niranjan R (2014) The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson’s disease: focus on astrocytes. Mol Neurobiol 49(1):28–38. doi:10.1007/s12035-013-8483-x

    Article  CAS  PubMed  Google Scholar 

  23. Bachmann CG, Trenkwalder C (2006) Body weight in patients with Parkinson’s disease. Mov Disord: Off J Mov Disord Soc 21(11):1824–1830. doi:10.1002/mds.21068

    Article  Google Scholar 

  24. Demir MV, Tamer A, Cinemre H et al (2015) Nutritional status and laboratory parameters among internal medicine inpatients. Niger J Clin Pract 18(6):757–761. doi:10.4103/1119-3077.158145

    Article  CAS  PubMed  Google Scholar 

  25. Gao X, O’Reilly EJ, Schwarzschild MA et al (2016) Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology 86(6):520–526. doi:10.1212/WNL.0000000000002351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

No funding source was used during the study.

Author information

Authors and Affiliations

  1. Department of Neurology, Huai’an First People’s Hospital, Nanjing Medical University, 6 Beijing Road West, Huai’an, 223300, Jiangsu, China

    Lijun Wang & Guanliang Cheng

  2. Center for Disease Control and Prevention of Huai’an City, Huai’an, 223001, China

    Wei Hu

  3. Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, 211166, China

    Jun Wang, Fangfang Fang & Hang Xiao

  4. Department of Medical Laboratory, Huai’an First People’s Hospital, Nanjing Medical University, 6 Beijing Road West, Huai’an, Jiangsu, 223300, China

    Yuzhang Jiang

  5. Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu, China

    Qi Wan

Authors
  1. Lijun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fangfang Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guanliang Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuzhang Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hang Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qi Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Hang Xiao or Qi Wan.

Ethics declarations

Conflict of interest

The authors declare no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, L., Hu, W., Wang, J. et al. Impact of serum uric acid, albumin and their interaction on Parkinson’s disease. Neurol Sci 38, 331–336 (2017). https://doi.org/10.1007/s10072-016-2738-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2738-z

Keywords

Search

Navigation